Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

40 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
[Gene expression analysis and its clinical use in breast tumors].
Semiglazov VF, Semiglazov VV, Moiseenko FV, Bogdanov AA, Boĭtsov VV, Viaz'min SV, Gorab DN, Chubenko VA, Brezhnev NV, Luk'ianchikova VS, Dubina MV. Semiglazov VF, et al. Among authors: moiseenko fv. Vopr Onkol. 2013;59(1):25-9. Vopr Onkol. 2013. PMID: 23805447 Review. Russian. No abstract available.
[Markers of effectiveness of preoperative taxane-based chemotherapy for locally advanced breast cancer].
Semiglazova TIu, Klimenko VV, Filatova LV, Chubenko VA, Krivorot'ko PV, Ivanov VG, Turkevich EA, Ivantsov AO, Novikov SN, Semiglazov VV, Donskikh RV, Moiseenko FV, Bus'ko EA, Briantseva ZhV, Osipov MA, Gershanovish ML, Imianitov EN, Semiglazov VF. Semiglazova TIu, et al. Among authors: moiseenko fv. Vopr Onkol. 2013;59(3):363-7. Vopr Onkol. 2013. PMID: 23909039 Clinical Trial. Russian.
Overall Survival of Patients With ALK-Positive Metastatic Non-Small-Cell Lung Cancer in the Russian Federation: Nationwide Cohort Study.
Tsimafeyeu I, Moiseenko F, Orlov S, Filippova E, Belonogov A, Nebesnykh A, Khalimov A, Karabina E, Shikina V, Abdelgafur A, Statsenko G, Titova I, Isaichikov D, Makarnyaeva G, Mordovskiy A, Barkovskaya O, Smirnov A, Gikalo M, Savelov N, Kosov D, Imyanitov E, Demidova I, Tjulandin S. Tsimafeyeu I, et al. J Glob Oncol. 2019 May;5:1-7. doi: 10.1200/JGO.19.00024. J Glob Oncol. 2019. PMID: 31095455 Free PMC article.
Monitoring of the presence of EGFR-mutated DNA during EGFR-targeted therapy may assist in the prediction of treatment outcome.
Moiseenko FV, Volkov NM, Zhabina AS, Stepanova ML, Rysev NA, Klimenko VV, Myslik AV, Artemieva EV, Egorenkov VV, Abduloeva NH, Ivantsov AO, Kuligina ES, Imyanitov EN, Moiseyenko VM. Moiseenko FV, et al. Cancer Treat Res Commun. 2022;31:100524. doi: 10.1016/j.ctarc.2022.100524. Epub 2022 Jan 31. Cancer Treat Res Commun. 2022. PMID: 35101831 Free article. Clinical Trial.
Tumor acidity: From hallmark of cancer to target of treatment.
Bogdanov A, Bogdanov A, Chubenko V, Volkov N, Moiseenko F, Moiseyenko V. Bogdanov A, et al. Front Oncol. 2022 Aug 29;12:979154. doi: 10.3389/fonc.2022.979154. eCollection 2022. Front Oncol. 2022. PMID: 36106097 Free PMC article. Review.
First-Line Lorlatinib or Crizotinib in Advanced ALK-Positive Lung Cancer.
Shaw AT, Bauer TM, de Marinis F, Felip E, Goto Y, Liu G, Mazieres J, Kim DW, Mok T, Polli A, Thurm H, Calella AM, Peltz G, Solomon BJ; CROWN Trial Investigators. Shaw AT, et al. N Engl J Med. 2020 Nov 19;383(21):2018-2029. doi: 10.1056/NEJMoa2027187. N Engl J Med. 2020. PMID: 33207094 Clinical Trial.
40 results